Gates charity to fund malaria vaccine research
C|Net | at | by Mike
The Bill & Melinda Gates Foundation on Sunday announced $258.3 million in new grants to fund the development of a vaccine and new drugs to combat malaria.
The Malaria Vaccine Initiative (MMV) will get $107.6 million, with which GlaxoSmithKline Biologicals and African researchers plan to test and license a malaria vaccine candidate in Africa over five-year period, the foundation said. Another $100 million has been allocated to the Medicines for Malaria Venture to fund the development of new malaria drugs. A third grant, of $50 million, will go to the Innovative Vector Control Consortium for promoting enhanced insecticides and mosquito control methods such as insecticide-treated bed nets.